Share
Fr. 146.00
JEANETTE MCCARTHY, Jeanette J. Mccarthy, Mccarthy J, McCarthy Jeanette, Bryce Mendelsohn, Bryce A. Mendelsohn...
Precision Medicine: A Guide to Genomics in Clinical Practice
English · Paperback / Softback
Shipping usually within 3 to 5 weeks
Description
Incorporate genomics into every applicable area of your clinical practice with this complete how-to guide
A Doody's Core Title for 2024 & 2022!
Precision Medicine: A Guide to Genomics in Clinical Practice is a comprehensive, yet succinct overview of the practice of genomic medicine. It is written for general healthcare practitioners, specialists, and trainees with the goal of providing detailed guidance on how to incorporate genomic medicine into daily practice.
Features that make this book valuable to every practice:
- Intentionally avoids excessive technical content and consistently emphasizes real-life patient care and decision support
- Follows the course of a human life, beginning before conception through pregnancy, childhood, and adulthood, discussing the current and future applications of genomics and precision medicine at each stage
- Organization allows healthcare providers to quickly and easily find the information relevant to their practice.
- The authors highlight common pitfalls - technical and ethical - that might complicate the delivery of quality genomic healthcare
- Enhanced by eleven valuable appendices that cover important topics ranging from the basics of genetics to ethical issues to regulation and reimbursement
If you are searching for a clinically relevant, non-technical resource that will teach you how genomic medicine can and should be practiced in your specific field of interest, Precision Medicine: A Guide to Genomics in Clinical Practice belongs on your desk.
List of contents
Chapters 1-4: Pregnancy and childhoodChapter 1: PreconceptionWhat are the applications of precision medicine in the preconception period?
- Infertility
- Carrier screening - traditional and expanded
- Genetic counselling, reimbursement, where to get tested
- Future prospects: Preimplantation genetic testing
- Carrier screening - traditional and expanded
- Triple/quad screening
- Amniocentesis/CVS
- Trisomy testing using non-invasive (cfDNA) methods
- Future prospects: expanded uses of cfDNA testing during pregnancy
- Amniocentesis/CVS
- Mandatory newborn screening
- Broad classification and evaluation of birth defects
- Broad classification and evaluation of metabolic disease
- Future prospects: Sequencing from birth
- Broad classification and evaluation of birth defects
- Autism and Developmental delay
- Childhood cancer (hereditary cancer)
- Rare diseases and diagnostic sequencing
- Support and advocacy for rare diseases
- Childhood cancer (hereditary cancer)
- Types of pharmacogenetic markers
- Efficacy-based, companion diagnostics
- Safety-based, avoiding severe adverse events
- Dosing-based
- Safety-based, avoiding severe adverse events
- Understanding CYP450 alleles
- Sources of information about pharmacogenetic tests
- Drug labels
- Evidence guidelines
- PharmGKB, Dutch group
- Evidence guidelines
- Predisposition/diagnostic testing for myocardial infarction, thrombosis risk, arrhythmias
- The utility of prognostic markers (e.g. CardioDx test)
- Managing dose, efficacy and side effects of cardiovascular drugs using pharmacogenomics
- Clopidogrel, Warfarin, Simvastatin
- Managing dose, efficacy and side effects of ID drugs using pharmacogenomics
- Diagnostic/predisposition testing for Hereditary cancers
- HBOC, Lynch Syndrome, rare hereditary cancer syndromes
- Managing dose, efficacy and side effects of cancer drugs using pharmacogenetics
- Irinotecan, Belinostat, Azothioprine, Capecitaban, Tamoxifen, Oliparib
- The genetic landscape of tumors
- Prognostic markers
- Targeted treatment and companion diagnostics
- Tumor profiling and expanded treatment options
- Future prospects: cfDNA for screening, diagnosing and monitoring cancer
Chapter 9: The Brain - Mental Health and NeurodegenerationHow is precision medicine being applied in mental health and neurodegenerative disease?- Predisposition/diagnostic testing for epilepsies, Alzheimer, Parkinson diseases
- Managing dose, efficacy and side effects of antidepressant, antipsychotic, anti-seizure drugs using pharmacogenomics
Appendices. Conceptual framework for understanding genomic and precision medicineAppendix 1: Genome variationDescribes the structure and organization of the human genome and the different types of variation, their consequences and distribution in different populations- DNA, RNA, Protein variation
- Origin and types of genetic (DNA) variation (from big to small)
- Consequences of genetic variation
- Patterns of genetic variation across populations and ancestry
- Origin and types of genetic (DNA) variation (from big to small)
- DNA variation (aCGH, karyotyping, FISH,Targeted genotyping, SNP arrays, Sanger and next-gen sequencing -whole genome, whole exome, panel)
- The unique mitochondrial genome
- RNA variation (QrtPCR, Transcript arrays, next-gen sequencing)
- Protein variation (IHC, mass spectrometry)
- Epigenome variation (Bisulfite sequencing)
- How to find a testing laboratory (general information, specifics discussed within each disease type)
- The unique mitochondrial genome
- Inheritance patterns
- Penetrance, expressivity, environmental influences
- Family history: why it still matters
- Penetrance, expressivity, environmental influences
- US FDA and genetic testing
- Insurance coverage of genomic tests in the US
with genetic testing?- Secondary/incidental findings
- Discrimination and GINA
- Privacy and sharing
- Testing minors
- Population screening
- Eugenics and disability rights
- How to gather appropriate informed consent
- Discrimination and GINA
About the author
Jeanette J. McCarthy, MPH, PhD (San Francisco, CA) Adjunct Associate Professor, University of California, San Francisco.
Bryce A. Mendelsohn, MD, PhD (San Francisco, CA) Medical Genetics Clinical Fellow, University of California, San Francisco.
Summary
A complete how-to-guide for incorporating precision medicine into any type of practice
- The utility of prognostic markers (e.g. CardioDx test)
- Efficacy-based, companion diagnostics
Product details
Authors | JEANETTE MCCARTHY, Jeanette J. Mccarthy, Mccarthy J, McCarthy Jeanette, Bryce Mendelsohn, Bryce A. Mendelsohn, Mendelsohn Bryce |
Publisher | McGraw-Hill |
Languages | English |
Product format | Paperback / Softback |
Released | 31.12.2017 |
EAN | 9781259644139 |
ISBN | 978-1-259-64413-9 |
Dimensions | 185 mm x 231 mm x 13 mm |
Weight | 404 g |
Illustrations | Illustrationen, nicht spezifiziert |
Series |
Internal Medicine |
Subjects |
Natural sciences, medicine, IT, technology
> Medicine
> Clinical medicine
MEDICAL / Diagnosis, MEDICAL / Genetics, MEDICAL / Microbiology, Medical microbiology & virology, Medical Genetics, Medical Diagnosis, Medical microbiology and virology |
Customer reviews
No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.
Write a review
Thumbs up or thumbs down? Write your own review.